The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study

The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study

To investigate the effect of rosuvastatin compared to placebo on the aortic stiffness in hemodialysis patients as measured by pulse wave velocity (at 3, 6 and 12 months)

Inclusion Criteria:

• Signed informed consent, between 50 and 80 years of age, end stage renal failure patients receiving hemodialysis

Exclusion Criteria:

• Received statins within past 6 months, a clear indication for use of lipid altering drug, contra indication for lipid altering drug, history of statin induced myopathy items in very